GlaxoSmithKline plc's (GSK) Hold Rating Reiterated at Shore Capital

GlaxoSmithKline plc's (GSK) Hold Rating Reiterated at Shore Capital


Several other brokerages have also recently weighed in on GSK. Citigroup Inc. reiterated a buy rating on shares of GlaxoSmithKline plc in a research report on Monday, November 7th.



from Biotech News